These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1945217)
1. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Polzin WJ; Kopelman JN; Robinson RD; Read JA; Brady K Obstet Gynecol; 1991 Dec; 78(6):1108-11. PubMed ID: 1945217 [TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies and growth retardation in intrauterine development. Spegiorin LC; Galão EA; De Godoy JM; Bagarelli LB; Oliani AH Prague Med Rep; 2007; 108(2):185-90. PubMed ID: 18225645 [TBL] [Abstract][Full Text] [Related]
3. Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy. Pattison NS; McKay EJ; Liggins GC; Lubbe WF N Z Med J; 1987 Feb; 100(817):61-4. PubMed ID: 3103033 [TBL] [Abstract][Full Text] [Related]
4. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Gleicher N; Pratt D; Dudkiewicz A Obstet Gynecol; 1992 Apr; 79(4):637-8. PubMed ID: 1622488 [No Abstract] [Full Text] [Related]
5. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Rosove MH; Tabsh K; Wasserstrum N; Howard P; Hahn BH; Kalunian KC Obstet Gynecol; 1990 Apr; 75(4):630-4. PubMed ID: 2107479 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy and lupus: prognostic indicators and response to treatment. Englert HJ; Derue GM; Loizou S; Hawkins DF; Elder MG; De Swiet M; Walport MJ; Hughes GR Q J Med; 1988 Feb; 66(250):125-36. PubMed ID: 3174925 [TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus]. Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352 [TBL] [Abstract][Full Text] [Related]
8. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Lackman F; Capewell V; Richardson B; daSilva O; Gagnon R Am J Obstet Gynecol; 2001 Apr; 184(5):946-53. PubMed ID: 11303203 [TBL] [Abstract][Full Text] [Related]
9. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Loizou S; Byron MA; Englert HJ; David J; Hughes GR; Walport MJ Q J Med; 1988 Jul; 68(255):525-31. PubMed ID: 3252304 [TBL] [Abstract][Full Text] [Related]
10. Beta2-glycoprotein I dependent anticardiolipin antibodies and lupus anticoagulant in patients with recurrent pregnancy loss. Kumar KS; Jyothy A; Prakash MS; Rani HS; Reddy PP J Postgrad Med; 2002; 48(1):5-10. PubMed ID: 12082318 [TBL] [Abstract][Full Text] [Related]
11. The significance of antiphospholipid antibodies in pregnant women with chronic hypertension. Zeeman GG; Alexander JM; McIntire DD; Leveno KJ Am J Perinatol; 2004 Jul; 21(5):275-9. PubMed ID: 15232760 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Lee RM; Branch DW; Silver RM Am J Obstet Gynecol; 2001 Sep; 185(3):748-53. PubMed ID: 11568809 [TBL] [Abstract][Full Text] [Related]
13. [Study of the causes of fetal growth restriction with unclear etiologies]. Zhao J; Wu LF Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):329-33. PubMed ID: 15196417 [TBL] [Abstract][Full Text] [Related]